1. From the Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, Valencia, Spain (J.P.-H., A.O., O.M.-A., D.P.-G., D.O., E.S., F.M., J.R., R.C.)
2. Departamento de Anatomía Patológica, Facultad de Medicina, Universidad de La Frontera, Temuco, Chile (A.L.R.-C.)
3. Internal Medicine Unit, Hospital Clínico Universitario, Valencia, Spain (E.S., F.M., J.R.)
4. Endocrinology and Nutrition Department Clinic Hospital, Spain (S.M.-H.)
5. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Institute of Health Carlos III, Minister of Health, Barcelona, Spain (S.M.-H., F.J.C.)
6. Department of Medicine, Faculty of Medicine and Odontology, University of Valencia, Spain (S.M.-H.)
7. Genomics and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, Spain (F.J.C.)
8. CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Minister of Health, Madrid, Spain (J.R.).